Literature DB >> 17699646

Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis.

Hans Hallander1, Abdolreza Advani, Marion Riffelmann, Carl H W von König, Valerie Caro, Nicole Guiso, Frits R Mooi, Anna Gzyl, Margit S Kaltoft, Norman K Fry, Jussi Mertsola, Qiushui He.   

Abstract

Clinical isolates of Bordetella pertussis collected during the year 2004 (n = 153) in eight European countries, Denmark, Finland, France, Germany, The Netherlands, Poland, Sweden, and United Kingdom, were analyzed by pulsed-field gel electrophoresis (PFGE), and their PFGE profiles were compared with those of isolates collected in 1999 (n = 102). The 255 isolates produced 59 distinct PFGE profiles. Among the 153 isolates from 2004, 36 profiles were found, while within the 102 isolates from 1999, 33 profiles were detected. One PFGE profile, BpSR11, was dominant (30% to 50%) in all countries except Denmark (10%) and Poland (0%). In comparison with 1999, there was an increase in BpSR11 prevalence in Finland in 2004 from 5% to 40%, coinciding with a major incidence peak. Some other PFGE profiles seemed to be associated with limited dissemination. Poland was the only country in which the most common actual European PFGE profiles were not found. In a dendrogram analysis, all common PFGE profiles were identified within PFGE group IV, and BpSR11 clustered together with PFGE subgroup IVbeta. Compared to the 1999 isolates, PFGE group V representative for pertactin variant prn3 strains had disappeared, and a new cluster was seen. In conclusion, some PFGE profiles, such as BpSR11, evidently have a higher capacity to spread, suggesting increased fitness to the present immunological environment. It is therefore of major interest to continue with surveillance programs of B. pertussis isolates, as both waning vaccine-derived immunity and strain variation may play a role in the persistence of pertussis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699646      PMCID: PMC2045341          DOI: 10.1128/JCM.00864-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology.

Authors:  F R Mooi; H Hallander; C H Wirsing von König; B Hoet; N Guiso
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-03       Impact factor: 3.267

2.  Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.

Authors:  C Weber; C Boursaux-Eude; G Coralie; V Caro; N Guiso
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Multilocus sequence typing of Bordetella pertussis based on surface protein genes.

Authors:  Inge H M van Loo; Kees J Heuvelman; Audrey J King; Frits R Mooi
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  Molecular epidemiology of Bordetella pertussis isolated in Taiwan, 1992-1997.

Authors:  Yeong-Sheng Lee; Chiou-Ying Yang; Cheng-Hsiung Lu; Yi-Hsiung Tseng
Journal:  Microbiol Immunol       Date:  2003       Impact factor: 1.955

5.  Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000.

Authors:  Peter McIntyre; Heather Gidding; Robin Gilmour; Glenda Lawrence; Brynley Hull; Peter Horby; Han Wang; Ross Andrews; Margaret Burgess
Journal:  Commun Dis Intell Q Rep       Date:  2002-05

6.  Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles.

Authors:  Abdolreza Advani; Declan Donnelly; Hans Hallander
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype.

Authors:  Abdolreza Advani; Lennart Gustafsson; Rose-Marie Carlsson; Declan Donnelly; Hans O Hallander
Journal:  APMIS       Date:  2007-06       Impact factor: 3.205

8.  Bordetella species are distinguished by patterns of substantial gene loss and host adaptation.

Authors:  C A Cummings; M M Brinig; P W Lepp; S van de Pas; D A Relman
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

9.  Pertussis resurgence in Canada largely caused by a cohort effect.

Authors:  Benoît Ntezayabo; Gaston De Serres; Bernard Duval
Journal:  Pediatr Infect Dis J       Date:  2003-01       Impact factor: 2.129

10.  Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

Authors:  F R Mooi; I H van Loo; A J King
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

View more
  21 in total

1.  Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type.

Authors:  David J Litt; Shona E Neal; Norman K Fry
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

2.  Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use.

Authors:  Ewa Mosiej; Ewa Augustynowicz; Monika Zawadka; Waldemar Dabrowski; Anna Lutyńska
Journal:  J Clin Microbiol       Date:  2011-02-09       Impact factor: 5.948

3.  Pulsed-field gel electrophoresis characterization of Bordetella pertussis clinical isolates circulating in Turkey in 2001-2009.

Authors:  S Nar Otgun; R Durmaz; A Karagoz; B Esen; M Ertek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-02       Impact factor: 3.267

4.  Strain variation and antigenic divergence among Bordetella pertussis circulating strains isolated from patients in Iran.

Authors:  Fatemah Sadeghpour Heravi; Vajihe Sadat Nikbin; Masomeh Nakhost Lotfi; Pouran Badiri; Nazanin Jannesar Ahmadi; Seyed Mohsen Zahraei; Fereshteh Shahcheraghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-09       Impact factor: 3.267

5.  Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.

Authors:  Abdolreza Advani; Hans O Hallander; Tine Dalby; Karen Angeliki Krogfelt; Nicole Guiso; Elisabeth Njamkepo; Carl Heinz Wirsing von Könnig; Marion Riffelmann; Frits R Mooi; Per Sandven; Anna Lutynska; Norman K Fry; Jussi Mertsola; Qiushui He
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

6.  Sequence variation in virulence-related genes of Bordetella pertussis isolates from Poland in the period 1959-2013.

Authors:  E Mosiej; M Zawadka; K Krysztopa-Grzybowska; M Polak; E Augustynowicz; K Piekarska; A Lutyńska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-05       Impact factor: 3.267

7.  Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.

Authors:  Frits R Mooi; Inge H M van Loo; Marjolein van Gent; Qiushui He; Marieke J Bart; Kees J Heuvelman; Sabine C de Greeff; Dimitri Diavatopoulos; Peter Teunis; Nico Nagelkerke; Jussi Mertsola
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

8.  Changes in the genomic content of circulating Bordetella pertussis strains isolated from the Netherlands, Sweden, Japan and Australia: adaptive evolution or drift?

Authors:  Audrey J King; Tamara van Gorkom; Han G J van der Heide; Abdolreza Advani; Saskia van der Lee
Journal:  BMC Genomics       Date:  2010-01-26       Impact factor: 3.969

9.  Effect of vaccination on Bordetella pertussis strains, China.

Authors:  Liu Zhang; Yinghua Xu; Jianhong Zhao; Teemu Kallonen; Shenghui Cui; Yunqiang Xu; Qiming Hou; Fengxiang Li; Junzhi Wang; Qiushui He; Shumin Zhang
Journal:  Emerg Infect Dis       Date:  2010-11       Impact factor: 6.883

10.  Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination.

Authors:  Valérie Bouchez; Valérie Caro; Erwan Levillain; Ghislaine Guigon; Nicole Guiso
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.